These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34060231)

  • 1. Structural and biochemical properties of L-asparaginase.
    Lubkowski J; Wlodawer A
    FEBS J; 2021 Jul; 288(14):4183-4209. PubMed ID: 34060231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate Affinity Is Not Crucial for Therapeutic L-Asparaginases: Antileukemic Activity of Novel Bacterial Enzymes.
    Ściuk A; Wątor K; Staroń I; Worsztynowicz P; Pokrywka K; Sliwiak J; Kilichowska M; Pietruszewska K; Mazurek Z; Skalniak A; Lewandowski K; Jaskolski M; Loch JI; Surmiak M
    Molecules; 2024 May; 29(10):. PubMed ID: 38792133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of active site mutant of antileukemic L-asparaginase reveals conserved zinc-binding site.
    Borek D; Kozak M; Pei J; Jaskolski M
    FEBS J; 2014 Sep; 281(18):4097-111. PubMed ID: 25040257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].
    Sokolov NN; Eldarov MA; Pokrovskaya MV; Aleksandrova SS; Abakumova OY; Podobed OV; Melik-Nubarov NS; Kudryashova EV; Grishin DV; Archakov AI
    Biomed Khim; 2015; 61(3):312-24. PubMed ID: 26215408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical review on properties and applications of microbial l-asparaginases.
    Krishnapura PR; Belur PD; Subramanya S
    Crit Rev Microbiol; 2016 Sep; 42(5):720-37. PubMed ID: 25865363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
    Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
    BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacterial L-asparaginase and glutamin(asparagin)ase: some properties, structure and anti-tumor activity].
    Sokolov NN; Zanin VA; Aleksandrova SS
    Vopr Med Khim; 2000; 46(6):531-48. PubMed ID: 11234278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine microbial L-asparaginase: Biochemistry, molecular approaches and applications in tumor therapy and in food industry.
    Izadpanah Qeshmi F; Homaei A; Fernandes P; Javadpour S
    Microbiol Res; 2018 Mar; 208():99-112. PubMed ID: 29551216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E. coli L-asparaginase V27T mutant: structural and functional characterization and comparison with theoretical predictions.
    Strzelczyk P; Zhang D; Wlodawer A; Lubkowski J
    FEBS Lett; 2022 Dec; 596(23):3060-3068. PubMed ID: 36310372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Catalysis by l-Asparaginase.
    Lubkowski J; Vanegas J; Chan WK; Lorenzi PL; Weinstein JN; Sukharev S; Fushman D; Rempe S; Anishkin A; Wlodawer A
    Biochemistry; 2020 May; 59(20):1927-1945. PubMed ID: 32364696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase: a promising chemotherapeutic agent.
    Verma N; Kumar K; Kaur G; Anand S
    Crit Rev Biotechnol; 2007; 27(1):45-62. PubMed ID: 17364689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
    Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
    J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
    Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [L-asparaginases of extremophilic microorganisms in biomedicine].
    Dumina MV; Eldarov MA; Zdanov DD; Sokolov NN
    Biomed Khim; 2020 Feb; 66(2):105-123. PubMed ID: 32420891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Insight into Substrate Selectivity of Erwinia chrysanthemi L-asparaginase.
    Nguyen HA; Su Y; Lavie A
    Biochemistry; 2016 Mar; 55(8):1246-53. PubMed ID: 26855287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEG-asparaginase.
    Fu CH; Sakamoto KM
    Expert Opin Pharmacother; 2007 Aug; 8(12):1977-84. PubMed ID: 17696798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and structural evaluation of the antileukaemic enzyme L-asparaginase II expressed at low temperature by different Escherichia coli strains.
    de Moura WAF; Schultz L; Breyer CA; de Oliveira ALP; Tairum CA; Fernandes GC; Toyama MH; Pessoa-Jr A; Monteiro G; de Oliveira MA
    Biotechnol Lett; 2020 Nov; 42(11):2333-2344. PubMed ID: 32638188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase.
    Aghaiypour K; Wlodawer A; Lubkowski J
    Biochemistry; 2001 May; 40(19):5655-64. PubMed ID: 11341830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in L-asparaginase discovery and its potential as anticancer agent.
    Shrivastava A; Khan AA; Khurshid M; Kalam MA; Jain SK; Singhal PK
    Crit Rev Oncol Hematol; 2016 Apr; 100():1-10. PubMed ID: 25630663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of L-asparaginase in childhood ALL.
    Müller HJ; Boos J
    Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.